(S)-2-AMINO-4-FLUORO-4-METHYLPENTANOIC ACID, 95.0%, 1g

3-(2,5-Dimethyl-2 H -pyrazol-3-yl)-3-oxo-propionic acid ethyl ester, 10g

5-chloro-2-isopropoxy-3-methoxybenzaldehyde, 95.0%, 1g

2-(((Benzyloxy)carbonyl)amino)-3-methylbutanoic acid, 95.0%, 500g

ISOPROPYL ((PERFLUOROPHENOXY)(PHENOXY)PHOSPHORYL)-L-ALANINATE, 95%, 1g

Phosphorous acid tris(trimethylsilyl)ester, 95%, 10g

DIMETHYL BIPHENYL-3,3'-DICARBOXYLATE, 95.0%, 1g

Ethyl 2-(2-aminopyrimidin-4-yl)acetate, 95.0%, 250mg

Obiettivo Plan PLPHi S40x/0.65 contrasto di fase IOS corretto all'infinito

1-BENZOYL-4-OXO-NIPECOTIC ACID ETHYL ESTER, 95.0%, 250mg

2-Methoxypyridin-4-ol, 99.0%, 10g

3,5-Dichloro-1,2,4-thiadiazole, 97.0%, 1g

1-(Benzyloxy)-4-bromo-3-chloro-2-methylbenzene, 98%, 1g